Recherche: GHRP-2

Growth hormone secretagogue — strong GH release with appetite increase

GHRP-2 Research Papers & Clinical Studies

GHRP-2 is a peptide studied for its potential therapeutic effects. Growth hormone secretagogue — strong GH release with appetite increase This page indexes all published research papers, clinical trials, and scientific studies related to GHRP-2 that are available in the PepsReview research library. Each paper includes metadata such as journal name, publication year, citation count, study type, and a summary of key findings. Where available, we provide direct links to the original publication and DOI references.

Researchers can use this index to quickly locate evidence supporting specific GHRP-2 applications, compare study designs, and evaluate the strength of clinical evidence. Papers are sorted by relevance and citation count. There are currently 5 research papers indexed for GHRP-2.

For vendor pricing, user reviews, and a complete peptide profile including mechanism of action, benefits, side effects, and regulatory status, visit the main GHRP-2 profile page.

GHRP-2

Pralmorelin: GHRP 2, GPA 748, growth hormone-releasing peptide 2, KP-102 D, KP-102 LN, KP-102D, KP-102LN

Drugs R D 2004 440 Research Article

Pralmorelin (GHRP-2) is an orally active synthetic growth hormone-releasing peptide that mimics ghrelin, regulating GH release, bone/muscle growth, and food intake.

Growth hormone releasing peptide-2 (GHRP-2), like ghrelin, increases food intake in healthy men

J Clin Endocrinol Metab 2005 420 Research Article

Study showing GHRP-2, like ghrelin, increases food intake in healthy men, demonstrating orexigenic effects through growth hormone secretagogue receptor activation.

Beyond the androgen receptor: the role of growth hormone secretagogues in the modern management of body composition in hypogonadal males

Transl Androl Urol 2020 120 Review

Review of growth hormone secretagogues for body composition management in hypogonadal males, where obesity and metabolic syndrome complicate testosterone-only therapy.

Clinical Usefulness of the Growth Hormone-Releasing Peptide-2 Test for Hypothalamic-Pituitary Disorder

J Endocr Soc 2022 80 Research Article

Study evaluating the clinical usefulness of the GHRP-2 loading test for diagnosing hypothalamic-pituitary disorders and assessing growth hormone deficiency.

Robust growth hormone responses to GH-releasing peptide 2 in adolescents

J Pediatr Endocrinol Metab 2024 40 Research Article

GHRP-2 produced robust GH responses in adolescents, with higher cut-off peak GH levels than other provocative tests, supporting use as a powerful GH stimulus.